Indonesia, one of the greatest population countries, contributes a sig-nificant increase of global prevalence of type 2 diabetes mellitus. The need of insulin treatment is significantly rising as many cases do not meet the recommended glycemic target with oral glycemic lowering drug (OGLD). However, there is a discrepancy between guidelines is-sued by the Ministry of Health of Indonesia through national formulary and the Indonesian Medical Council through Indonesian medical stan-dard of competency. Here, we described our point of view about the situation of diabetes mellitus in Indonesia, a matter of insulin availability in public health centre, and recommendations to solve this issue.
Key words: Diabetes, Health services, Insulin, Primary health care
|
